- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of NK Cells and Innate Lymphoid Cells in Brain Cancer
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-31
DOI
10.3389/fimmu.2020.01549
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of group 2 innate lymphoid cells alleviates aging-associated cognitive decline
- (2020) Ivan Ting Hin Fung et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways
- (2020) Xiangqi Meng et al. Nature Communications
- Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function
- (2020) Gustavo Rodrigues Rossi et al. Frontiers in Immunology
- Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells
- (2019) Jesus Luna et al. Cancers
- Exploiting NK Cell Surveillance Pathways for Cancer Therapy
- (2019) Alexander Barrow et al. Cancers
- Testosterone Promotes Glioblastoma Cell Proliferation, Migration, and Invasion Through Androgen Receptor Activation
- (2019) Dulce Carolina Rodríguez-Lozano et al. Frontiers in Endocrinology
- Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI
- (2019) Bridget A. Kennis et al. JOURNAL OF NEURO-ONCOLOGY
- Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis
- (2019) Harald Krenzlin et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas
- (2019) Michael Bockmayr et al. Cancer Immunology Research
- The Natural Cytotoxicity Receptors in Health and Disease
- (2019) Alexander David Barrow et al. Frontiers in Immunology
- Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer
- (2019) Eda K. Holl et al. Frontiers in Immunology
- Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma
- (2019) Chen Zhu et al. OncoImmunology
- Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival
- (2019) Andrea Gras Navarro et al. Cancers
- Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
- (2019) Allison B. Powell et al. Journal of Translational Medicine
- A gene expression-based study on immune cell subtypes and glioma prognosis
- (2019) Qiu-Yue Zhong et al. BMC CANCER
- Identification of 3 subpopulations of tumor-infiltrating immune cells for malignant transformation of low-grade glioma
- (2019) Jiacheng Lu et al. Cancer Cell International
- Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases
- (2019) Gildas Lepennetier et al. Journal of Neuroinflammation
- MHC-II neoantigens shape tumour immunity and response to immunotherapy
- (2019) Elise Alspach et al. NATURE
- Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
- (2019) Anna Galstyan et al. Nature Communications
- The Central Nervous System Contains ILC1s That Differ From NK Cells in the Response to Inflammation
- (2019) Silvina Romero-Suárez et al. Frontiers in Immunology
- CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
- (2019) Michael C. Burger et al. Frontiers in Immunology
- Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
- (2019) H. J. Close et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
- (2018) Alexander D. Barrow et al. CELL
- Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors
- (2018) Nathan J. Robison et al. JOURNAL OF NEURO-ONCOLOGY
- Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+T cell trafficking
- (2018) David Taggart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility
- (2018) Abigail E. Russi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis
- (2018) Iryna Saranchova et al. Scientific Reports
- Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors–Human Leukocyte Antigen Ligand Mismatch and Activation Receptor–Ligand Interactions
- (2018) Heleen Neeltje Haspels et al. Frontiers in Immunology
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas
- (2018) Feifei Ren et al. IMMUNOLOGY AND CELL BIOLOGY
- NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
- (2018) Marcus Ruscetti et al. SCIENCE
- Innate lymphoid cell sensing of tissue vitality
- (2018) Alexander David Barrow et al. CURRENT OPINION IN IMMUNOLOGY
- Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma—A phase II multicentric, randomised study
- (2017) Renata Ursu et al. EUROPEAN JOURNAL OF CANCER
- High-dimensional, single-cell characterization of the brain's immune compartment
- (2017) Ben Korin et al. NATURE NEUROSCIENCE
- Global incidence of malignant brain and other central nervous system tumors by histology, 2003–2007
- (2017) Rebecca Leece et al. NEURO-ONCOLOGY
- IL-33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway
- (2017) Jian-Fei Zhang et al. ONCOLOGY REPORTS
- Tailoring Natural Killer cell immunotherapy to the tumour microenvironment
- (2017) Alexander David Barrow et al. SEMINARS IN IMMUNOLOGY
- High expression of B7-H6 in human glioma tissues promotes tumor progression
- (2017) Tianwei Jiang et al. Oncotarget
- Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs
- (2017) Anna Kozlowska et al. Journal of Cancer
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Tumor infiltrating immune cells in gliomas and meningiomas
- (2016) Patrícia Domingues et al. BRAIN BEHAVIOR AND IMMUNITY
- Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells
- (2016) Anna K. Kozlowska et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients
- (2016) Mev Dominguez–Valentin et al. CANCER RESEARCH
- Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy
- (2016) J. Y. Yoo et al. CLINICAL CANCER RESEARCH
- Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity
- (2016) C. M. Suryadevara et al. CLINICAL CANCER RESEARCH
- Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury
- (2016) Sachin P. Gadani et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immune phenotypes predict survival in patients with glioblastoma multiforme
- (2016) Haouraa Mostafa et al. Journal of Hematology & Oncology
- Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model
- (2016) Mitsuto Hanihara et al. JOURNAL OF NEUROSURGERY
- Single-cell analysis defines the divergence between the innate lymphoid cell lineage and lymphoid tissue–inducer cell lineage
- (2016) Isabel E Ishizuka et al. NATURE IMMUNOLOGY
- Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
- (2016) Christoph S N Klose et al. NATURE IMMUNOLOGY
- Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation
- (2016) Qiang Liu et al. NATURE NEUROSCIENCE
- IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression
- (2016) Xiaoran Zhang et al. NEURO-ONCOLOGY
- Natural killer cells require monocytic Gr-1+/CD11b+ myeloid cells to eradicate orthotopically engrafted glioma cells
- (2016) Gregory J. Baker et al. OncoImmunology
- Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
- (2015) Se Jeong Lee et al. BMC CANCER
- TGF Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response
- (2015) J. Han et al. CANCER RESEARCH
- Group 3 innate lymphoid cells accumulate and exhibit disease-induced activation in the meninges in EAE
- (2015) Julianne K. Hatfield et al. CELLULAR IMMUNOLOGY
- A NK complex-linked locus restricts the spread of herpes simplex virus type 1 in the brains of C57BL/6 mice
- (2015) Lorne F Kastrukoff et al. IMMUNOLOGY AND CELL BIOLOGY
- Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
- (2015) Nadja Müller et al. JOURNAL OF IMMUNOTHERAPY
- Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells
- (2015) Han-Ching Tseng et al. Journal of Cancer
- Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
- (2015) D. A. Reardon et al. Cancer Immunology Research
- Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
- (2015) Aurelie Poli et al. Oncotarget
- CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
- (2015) Jianfeng Han et al. Scientific Reports
- Natural Killer Cells Eradicate Galectin-1-Deficient Glioma in the Absence of Adaptive Immunity
- (2014) G. J. Baker et al. CANCER RESEARCH
- NK Cells with KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival
- (2014) Andrea Gras Navarro et al. JOURNAL OF IMMUNOLOGY
- Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10
- (2014) Yao Zhang et al. Journal of Neuroinflammation
- Transforming growth factor-beta and its implication in the malignancy of gliomas
- (2014) Laurent-Olivier Roy et al. Targeted Oncology
- Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma
- (2014) Justyna Kmiecik et al. OncoImmunology
- Targeting TGF-β signaling in cancer
- (2013) Lior H Katz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?
- (2013) Walter H Meisen et al. Expert Review of Neurotherapeutics
- Treg depletion followed by intracerebral CpG-ODN injection induce brain tumor rejection
- (2013) Ulrich Jarry et al. JOURNAL OF NEUROIMMUNOLOGY
- In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
- (2013) Lucia Fernández et al. Frontiers in Oncology
- Immunophenotypic Identification and Characterization of Tumor Cells and Infiltrating Cell Populations in Meningiomas
- (2012) Patrícia H. Domingues et al. AMERICAN JOURNAL OF PATHOLOGY
- Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers
- (2012) Hui Ding et al. BIOMATERIALS
- Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma
- (2012) F. Cedeno-Laurent et al. BLOOD
- Immune genes are associated with human glioblastoma pathology and patient survival
- (2012) Elodie Vauléon et al. BMC Medical Genomics
- NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
- (2012) Christopher A Alvarez-Breckenridge et al. NATURE MEDICINE
- The Cancer Stem Cell Subtype Determines Immune Infiltration of Glioblastoma
- (2012) Christoph P. Beier et al. STEM CELLS AND DEVELOPMENT
- Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology
- (2011) Isaac Yang et al. JOURNAL OF NEUROSURGERY
- TGF- downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients
- (2011) C. A. Crane et al. NEURO-ONCOLOGY
- Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
- (2011) A. Carpentier et al. NEURO-ONCOLOGY
- Induction of Anti-Glioma Natural Killer Cell Response following Multiple Low-Dose Intracerebral CpG Therapy
- (2010) D. Alizadeh et al. CLINICAL CANCER RESEARCH
- NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
- (2009) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
- (2008) A. Soriani et al. BLOOD
- Plasmacytoid dendritic cells induce NK cell–dependent, tumor antigen–specific T cell cross-priming and tumor regression in mice
- (2008) Chengwen Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started